
Novel hHDAC6 ингибитор, having low inhibitory potency over hHDAC1 and hHDAC8, as potential pharmacological tools for idiopathic pulmonary fibrosis (IPF) treatment
Novel hHDAC6 inhibitor, having low inhibitory potency over hHDAC1 and hHDAC8, as potential pharmacological tools for idiopathic pulmonary fibrosis (IPF) treatment
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.